Unibest

Pharmaceutical intermediates

Voxelotor Intermediates

4 pharmaceutical intermediates for Voxelotor. Indication: Anemia, Sickle Cel; Anemia, Hemolytic.

提交项目All intermediates

About Voxelotor

Originator
Global Blood Therapeutics Inc
Indication
Anemia, Sickle Cel; Anemia, Hemolytic
Approved Date
11/25/2019
DS/DP
12/28/2032

Available intermediates

4 intermediates currently listed for Voxelotor. Request specifications, documentation or a quotation for any item below.

Voxelotor intermediates
Product NameCAS No.Molecular FormulaPhysical Properties
(2-Chloro-3-pyridinyl)methanol42330-59-6//
1-Isopropyl-1H-pyrazole-5-boronic acid, pinacol ester1282518-60-8//
2-hydroxy-6-(methoxymethoxy)benzaldehyde84290-49-3//
3-(chloromethyl)-2-(1-isopropyl-1H-pyrazol-5-yl)pyridine hydrochloride1446321-95-4//

Other programs under V

Valbenazine Tosylate (NBI-98854)Varenicline TartrateVelpatasvirVenetoclaxVericiguatVibegronVilazodone HydrochlorideVONOPRAZAN FUMARATE

Building toward Voxelotor?

Tell us the step you need covered and the specification you are filing against. We will confirm supply, documentation and lead time.

提交项目 联系团队

我们能如何帮助您？

获取最新活动与法规动态洞察

直接发送到您的邮箱

在此获取行业洞察与 Unibest 动态

联系我们 →